<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2007-7459</journal-id>
<journal-title><![CDATA[Horizonte sanitario]]></journal-title>
<abbrev-journal-title><![CDATA[Horiz. sanitario]]></abbrev-journal-title>
<issn>2007-7459</issn>
<publisher>
<publisher-name><![CDATA[Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de la Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2007-74592020000200277</article-id>
<article-id pub-id-type="doi">10.19136/hs.a19n2.3685</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prescripciones de benzodiacepinas y barbitúricos en Costa Rica 2011-2015]]></article-title>
<article-title xml:lang="en"><![CDATA[Benzodiazepines and barbiturates prescriptions in Costa Rica 2011-2015]]></article-title>
<article-title xml:lang="pt"><![CDATA[Prescriçãode benzodiazepinas e barbitúricos na Costa Rica 2011-2015]]></article-title>
<article-title xml:lang="fr"><![CDATA[Prescriptions de benzodiazépines et de barbituriques au Costa Rica 2011-2015]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cubero Alpízar]]></surname>
<given-names><![CDATA[Consuelo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas Valenciano]]></surname>
<given-names><![CDATA[Ligia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Campos Fernández]]></surname>
<given-names><![CDATA[Mauricio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Soto]]></surname>
<given-names><![CDATA[Luis Esteban]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Costa Rica  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de Costa Rica  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de Illinois  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>EEUU</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Costa Rica  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>08</month>
<year>2020</year>
</pub-date>
<volume>19</volume>
<numero>2</numero>
<fpage>277</fpage>
<lpage>290</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2007-74592020000200277&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2007-74592020000200277&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2007-74592020000200277&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo Identificar la prescripción de benzodizepinas y barbitúricos psicotrópicos: Clobazam, Tiopental, Clonazepam, Lorazepam, Fenobarbital y Diazepam en la Caja Costarricense del Seguro Social (CCSS) en Costa Rica en el periodo 2011-2015.  Materiales y métodos La población estuvo constituida por 1 488 989 prescripciones de psicotrópicos dentro de la CCSS en Costa Rica en el periodo de enero del 2011 a diciembre del 2015. El estudio es de tipo descriptivo retrospectivo.  Resultados Del total analizado, casi la mitad (un 47,15%) corresponden a Clonazepam. Le siguen el Lorazepam y el Diazepam con un 22,80% y un 22,53%, respectivamente. Finalmente, Fenobarbital, Clobazam y Tiopental son las menos prescritas con un 7,07%, 0,24% y 0,22% respectivamente. En cuanto a la distribución por sexo las mujeres recibieron el 62,65% de las prescripciones, el restante 37,35% fueron para hombres.  Conclusión Existe un aumento exponencial en el consumo de estos fármacos en el quinquenio en estudio. Las personas al final de su ciclo productivo (40 años o más) alcanzan los mayores porcentajes de consumo que luego decrecen alrededor de los 70 años o más; las mujeres son a quienes más se les prescriben este tipo de medicamentos. Por tanto, es necesaria una monitorización continúa que favorezca un uso adecuado de estos fármacos y evite generar potenciales problemas a la salud de la población especialmente a los adultos mayores.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective  To identify the prescription of benzodiazepines and psychotropic barbiturates: Clobazam, Thiop ental, Clonazepam, Lorazepam, Phenobarbital and Diazepam at the Costa Rican Social Security Fund (CCSS) in Costa Rica in the period 2011-2015.  Materials and methods  The population was constituted by 1 488 989 prescriptions of psychotropics within the CCSS in Costa Rica in the period from January 2011 to December 2015. The study is of a retrospective descriptive type.  Results  Of the total analyzed, almost half (47.15%) corresponded to Clonazepam. It is followed by Lorazepam and Diazepam with 22.80% and 22.53%, respectively. Finally, Phenobarbital, Clobazam and Thiopental are the least prescribed with 7.07%, 0.24% and 0.22% respectively. In terms of gender distribution, women received 62.65% of prescriptions, while the remaining 37.35% were for men.  Conclusion  There is an exponential increase in the consumption of these drugs in the five-year period under study. People at the end of their productive cycle (40 years or more) reached the highest percentages of consumption, which then fell to around 70 years or more; women were prescribed this type of drug the most. Therefore, continuous monitoring is necessary in order to promote the adequate use of these drugs and avoid generating potential health problems in the population, especially among the elderly.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objectivo Identificar a prescrição de benzodiazepinas e barbitúricos psicotrópicos: Clobazam, Thiopental, Clonazepam, Lorazepam, Phenobarbital e Diazepam no Fundo de Seguraba Social da Costa Rica (CCSS), na Costa Rica, no período 2011-2015.  Materiais e métodos A população foi constituida por 1 488 989 prescribes de psicotrópicos dentro do CCSS na Costa Rica, no período de Janeiro de 2011 a Dezembro de 2015. O estudo é de tipo descritivo retrospectivo.  Resultados  Do total analisado, quase metade (47,15%) correspondia ão Clonazepam. Segue-se Lorazepam e Diazepam com 22,80% e 22,53%, respectivamente. Finalmente, Phenobarbital, Clobazam e Thiopental são os menos prescritos com 7,07%, 0,24% e 0,22%, respectivamente. Em termos de distribuição por género, as mulheres receberam 62,65% das receitas, enquanto os restantes 37,35% foram para os homens.  Conclusão  Verifica-se um aumento exponencial do consumo destes medicamentos no periodo de cinco anos em estudo. As pessoas no final do seu ciclo produtivo (40 anos ou mais) atingiram as percentagens mais elevadas de consumo, que depois diminuíram para cerca de 70 anos ou mais; as mulheres foram as que mais receitaram este tipo de medicamentos. Por conseguinte, é necessário um acompanhamento continuo a fim de promover o uso adequado destes medicamentos e evitar a criação de potenciais problemas de saúde na população, especialmente entre os idosos.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[Résumé  Objectif Identifier la prescription de benzodiazépines et de barbituriques psychotropes : Clobazam, Thiopental, Clonazepam, Lorazepam, Phenobarbital et Diazepam, dans les établissements de la Caisse Costaricienne de Sécurité Sociale (CCSS), au Costa Rica, durant la période 2011-2015.  Matériels et méthodes La population a été constituée de 1 488 989 prescriptions de psychotropes au sein de la CCSS au Costa Rica durant la période de janvier 2011 a décembre 2015. L'étude est de type descriptif rétrospectif.  Résultats Sur le total des prescriptions analysées, pres de la moitié (47,15 %) correspondent au Clonazépam. Viennent ensuite le Lorazépam et le Diazépam (22,80 % et 22,53 % respectivement). Enfin, le Phénobarbital, le Clobazam et le Thiopental sont les moins prescrits (7,07%, 0,24% et 0,22% respectivement). En termes de distribution par sexe, les femmes ont reçu 62,65 % des prescriptions, les 37,35 % restants ont été destinés aux hommes.  Conclusion On observe une augmentation exponentielle de la consommation de ces substances au cours des cinq années a l&#8217;étude. Les pourcentages de consommation les plus élevés correspondent aux personnes arrivant a la fin de l&#8217;étape du cycle de vie généralement la plus productive (40 ans ou plus) ; ils diminuent ensuite aux alentours de 70 ans ou plus. Les femmes reçoivent plus fréquemment ce type de prescriptions. Une surveillance continue est donc nécessaire afin de promouvoir l'utilisation adéquate de ces substances et d'éviter de générer d&#8217;éventuels problemes de santé dans la population, en particulier chez les personnes âgées.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Prescripciones de Medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Benzodiazepinas]]></kwd>
<kwd lng="es"><![CDATA[Barbitúricos]]></kwd>
<kwd lng="es"><![CDATA[Sistemas de Medicación]]></kwd>
<kwd lng="en"><![CDATA[Drugprescriptions]]></kwd>
<kwd lng="en"><![CDATA[Benzodiazepines]]></kwd>
<kwd lng="en"><![CDATA[Barbiturates]]></kwd>
<kwd lng="en"><![CDATA[Medication systems]]></kwd>
<kwd lng="pt"><![CDATA[Prescrição de medicamentos]]></kwd>
<kwd lng="pt"><![CDATA[Benzodiazepinas]]></kwd>
<kwd lng="pt"><![CDATA[Barbitúricos]]></kwd>
<kwd lng="pt"><![CDATA[Sistemas medicinais]]></kwd>
<kwd lng="fr"><![CDATA[Prescription de médicaments]]></kwd>
<kwd lng="fr"><![CDATA[Benzodiazépines]]></kwd>
<kwd lng="fr"><![CDATA[Barbituriques]]></kwd>
<kwd lng="fr"><![CDATA[Systemes de médication]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carrasco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Atuy]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Cordero]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El envejecimiento demográfico, un reto desde las políticas públicas en el municipio Placetas en Villa Clara]]></article-title>
<source><![CDATA[Novedades en Població]]></source>
<year>2017</year>
<volume>25</volume>
<page-range>32-42</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[a]]></surname>
<given-names><![CDATA[Alvarado]]></given-names>
</name>
<name>
<surname><![CDATA[Salazar]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Análisis del concepto de envejecimiento]]></article-title>
<source><![CDATA[Gerokomos]]></source>
<year>2014</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>57-62</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morales-Martínez]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El envejecimiento en Costa Rica: una perspectiva actual y futura]]></article-title>
<source><![CDATA[Acta méd. Costarric]]></source>
<year>2015</year>
<volume>57</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moraros]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nwankwo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Patten]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Mousseau]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis]]></article-title>
<source><![CDATA[Depression and Anxiety]]></source>
<year>2017</year>
<volume>34</volume>
<page-range>217-26</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bareis]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sando]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Mezuk]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association Between Psychotropic Medication Polypharmacy and an Objective Measure of Balance Impairment Among Middle-Aged Adults: Results from the US National Health and Nutrition Examination Survey]]></article-title>
<source><![CDATA[CNS Drugs]]></source>
<year>2018</year>
<volume>32</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>863-71</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Salech]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Palma]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Garrido]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología del uso de medicamentos en la adultez mayor]]></article-title>
<source><![CDATA[Rev. Med. Clin. CONDES]]></source>
<year>2016</year>
<volume>27</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>660-70</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martinez-Cengotitabengoa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Diaz-Gutierrez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Besgaa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bermúdez- Ampudia]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lópeza]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rondon]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Stewartg]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Pereza]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gutierreza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez-Pintoa]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescripción de benzodiacepinas y caídas en mujeres y hombres ancianos]]></article-title>
<source><![CDATA[Revista de Psiquiatría y Salud Mental]]></source>
<year>2018</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cerecedo]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tovar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rozadilla]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalización de la vida en la consulta: ¿hacia dónde caminamos?]]></article-title>
<source><![CDATA[Atención Primaria]]></source>
<year>2013</year>
<volume>45</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>536-40</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aguilar]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalización de la vida]]></article-title>
<source><![CDATA[Rev.Urug.Cardiol]]></source>
<year>2015</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orueta]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[GonzV°lez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Fagundo]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Alejandre]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Carmona]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[MedicalizaciV&#8805;n de la vida (I)]]></article-title>
<source><![CDATA[Rev Clin Med Fam]]></source>
<year>2011</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>150-61</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corponi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Fabbri]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Serretti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacogenetics in Psychiatry]]></article-title>
<source><![CDATA[Advances in Pharmacology]]></source>
<year>2018</year>
<volume>83</volume>
<page-range>297-331</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<collab>UCR</collab>
<source><![CDATA[Envejecimiento de la población y alto gasto en medicamentos retan la sostenibilidad de la Caja]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>Normativa de la Lista Oficial de Medicamentos</collab>
<article-title xml:lang=""><![CDATA[de la Caja Costarricense del Seguro Social (CCSS)]]></article-title>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murguía]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ordorika]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lendo]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El estudio de los procesos de medicalización en América Latina]]></article-title>
<source><![CDATA[Hist. cienc. saude- Manguinhos]]></source>
<year>2016</year>
<volume>23</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofmann]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medicalization and overdiagnosis: different but alike]]></article-title>
<source><![CDATA[Med Health Care Philos]]></source>
<year>2016</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>25 3-64</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Billioti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bégaud]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Bazin]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepine use and risk of dementia: prospective population based study]]></article-title>
<source><![CDATA[BMJ]]></source>
<year>2012</year>
<page-range>345:e6231</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valdivia]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Casique]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumo de drogas psicotrópicas y capacidades de autocuidado en mujeres de Tepic, Nayarit]]></article-title>
<source><![CDATA[Enferm. glob]]></source>
<year>2015</year>
<volume>14</volume>
<numero>37</numero>
<issue>37</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Léon]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Macuer]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Alves]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unso de benzodiazepinas en adultos mayors en América Latina]]></article-title>
<source><![CDATA[Rev Med Chile]]></source>
<year>2017</year>
<volume>145</volume>
<page-range>351-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liotta]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Canhão]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Cenko]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Active Ageing in Europe: Adding Healthy Life to Years]]></article-title>
<source><![CDATA[Front Med (Lausanne)]]></source>
<year>2018</year>
<volume>5</volume>
<numero>123</numero>
<issue>123</issue>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arnold]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Straube]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Himmel]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High prevalence of prescription of psychotropic drugs for older patients in a general hospital]]></article-title>
<source><![CDATA[BMC Pharmacology &amp; Toxicology]]></source>
<year>2017</year>
<volume>18</volume>
<page-range>76</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ezzat]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Müller-Barna]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Krüger]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Randzio]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescription of Psychotropic Drugs with Potentially Restraining Effect: An Analysis of Care Need Assessment Data by MDK Bayern]]></article-title>
<source><![CDATA[Gesundheitswesen]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sotoca]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Anglada]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Molas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fontanals]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rovira]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sebastian]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aplicación de los nuevos criterios de prescripción inapropiada STOPP-START a pacientes geriátricos institucionalizados]]></article-title>
<source><![CDATA[Farm Aten Primaria]]></source>
<year>2011</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>2-7</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutierrez]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benzodiazepinas en ancianos: a próposito de un caso]]></article-title>
<source><![CDATA[Pahrm Care Esp]]></source>
<year>2015</year>
<volume>17</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>763-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sundseth]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Gjelstad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Straand]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rosvold]]></surname>
<given-names><![CDATA[EO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescripciones de médicos generales de benzodiacepinas, hipnóticos Z y analgésicos opioides para pacientes de edad avanzada durante contactos directos e indirectos. Un estudio transversal, observacional]]></article-title>
<source><![CDATA[Scand J Prim Health Care]]></source>
<year>2018</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>115-22</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pohontsch]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Heser]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Loffler]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Opiniones de los médicos generales sobre la prescripción (a largo plazo) y el uso de medicamentos problemáticos y potencialmente inapropiados para pacientes de edad avanzada: un estudio de entrevista cualitativa con médicos de cabecera (estudio CIM-TRIAD)]]></article-title>
<source><![CDATA[BMC Fam Pract]]></source>
<year>2017</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cornaggia]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Beghi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mezzanzanica]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychotropic Drug Consumption and Employment Status in Time of Economic Crisis (2007-2011)]]></article-title>
<source><![CDATA[Psychiatr Q]]></source>
<year>2017</year>
<volume>88</volume>
<page-range>371</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vilaça]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vieira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Fernandes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Esteves]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización del uso de benzodiacepinas en una población mayor registrada en unidades de salud familiar en la región de Minho, Portugal]]></article-title>
<source><![CDATA[Geriatría (Basilea)]]></source>
<year>2019</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bourin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The problems with the use of benzodiasepines in elderly patients]]></article-title>
<source><![CDATA[L Encéphale]]></source>
<year>2010</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>340-7</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cubero]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescripción de lorazepam dentro de la caja Costarricense del seguro social]]></article-title>
<source><![CDATA[Journal Health NPEPS]]></source>
<year>2019</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>70-89</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cubero]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prescripción de clonazepam en Costa Rica]]></article-title>
<source><![CDATA[Revista Española de drogodependencias]]></source>
<year>2018</year>
<volume>43</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
